However, the most common and well-known examples are the pathogenic BRCA1 and BRCA2 genomic variants, present in 1 to 300–500 women and responsible for 5–10% of breast cancers, and 10–15% of ovarian cancers [3,4,6,7,8,9]. This evidence concerns the gene BRCA1 and breast carcinoma.